semaglutide april 22 The FDA has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing FDA approves obesity drug that

A microbiome-focused approach typically includes: Supporting beneficial bacteria Promoting short-chain fatty acid production Maintaining gut lining health For readers interested in a more applied option within this microbiome-centered approach, Boost Synergy GLP-1 can be explored as part of broader support for SCFA pathways, gut barrier function, and natural GLP-1 signaling

5b and Supplementary Fig

When estradiol levels start to decline as women age or they transit to menopause, the protective effect of estradiol is lost (210)

Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal